Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.
Sathej M GopalakrishnanAkshanth R PolepallySven MensingAmit KhatriRajeev M MenonPublished in: Clinical pharmacokinetics (2017)
Population pharmacokinetic modeling did not reveal any patient-related or clinical parameters that would require dose adjustment of the 2D regimen when used for the treatment of HCV genotype 1b infection in Japanese patients.